Navigation Links
Norovirus Aboard Cruise Ship Marco Polo Rapidly Eradicated by Revolutionary new Vaporisation Process
Date:8/19/2009

LONDON, August 19 /PRNewswire/ -- The cruise ship Marco Polo, whose round-Britain cruise had to be cancelled because hundreds of passengers became ill with the vomiting bug Norovirus, has been totally disinfected by SitexOrbis' revolutionary infection control fogging service in just 5 hours at the Tilbury docks.

During that time 375 rooms on 11 decks plus public spaces, lifts and communal areas were disinfected.

Infection control powered by Activ8(TM) is available from SitexOrbis, the only company certified to offer the vaporisation process as per the industry standard. The antibacterial agent, Activ8(TM) is of proven biological efficacy and kills 99.99% of all known viruses and bacteria, both airborne and on surfaces, in minutes.

"The sheer speed with which SitexOrbis have solved the problem has been amazing" commented Christian Verhounig of the ship's operator. "We are extremely impressed, as it took only a few hours to disinfect the ship, rather than days of cleansing by traditional methods."

David Walker, Chief Executive of SitexOrbis, said "We are delighted to have been able to provide rapid assistance to ensure that the ship is disinfected and back in operation."

The SitexOrbis infection control process fills every space in the premises with a 'vapour' of Activ8(TM), which is totally harmless to human beings and animals, but kills 99.99% of life threatening bacteria and viruses, including salmonella, MRSA, Clostridium Difficile, SARS, Listeria, avian flu and H5N1 influenza A type viruses. A similar strain of influenza virus H1N1 is apparently responsible for the current swine 'flu outbreak.

Activ8(TM) is frequently used by SitexOrbis teams in schools, hospitals, offices, leisure facilities and workplaces where Norovirus outbreaks can occur. It is estimated that Norovirus affects between 600,000 and 1 million people a year in the UK. The disinfectant Activ8(TM)has been scientifically tested to be totally effective against Norovirus and other pathogens. The treatment of rooms only takes a few minutes with a minimum of disruption and, after sealing the premises for just an hour, the space is safe and ready to use again. Because of its speed and capabilities, it is more cost-effective than traditional steam-cleaning and less disruptive.

As with all disinfection processes, Activ8(TM) cannot prevent re-infection of those using premises, or a ship, by new visitors or passengers who carry the virus. The incubation period of Norovirus is between 24 and 48 hours, so reappearance of the infection weeks after disinfection is no reflection on the effectiveness of the Activ8(TM) service.

About SitexOrbis

SitexOrbis, http://www.sitexorbis.com, is the UK's leading provider of vacant property protection and management services. With over 25 years' experience in people and property protection solutions and integrated services, SitexOrbis is trusted by more than 1000 clients. The SitexOrbis group of companies generates turnover in excess of GBP40 million and employs more than 600 people. The group includes companies in the U.K., Ireland, Germany, France, the Netherlands and Belgium. The new European brand and company name, SitexOrbis, reflects the group's increased activity on a pan-European level.

SitexOrbis has recently brought to the market a new infection control vaporisation service using Activ8(TM), which is totally harmless to human beings or animals, but kills 99.99% of life threatening bacteria and viruses, including Salmonella, MRSA, Clostridium Difficile, SARS, Listeria, Norovirus, Avian Flu and H5N1 influenza A-type viruses. Activ8(TM) has been proven in laboratory tests to be effective against similar strains of the viruses responsible for Swine Flu

outbreak. Activ8(TM) is frequently used in schools, colleges and universities, hospitals, offices, leisure facilities and workplaces where infections can occur.

SitexOrbis has also launched new technologies and products to boost commercial property security. A new remotely programmable one-key-for-all-locks technology at the heart of SitexOrbis' eMAKS Electronically Managed Access Key Systems is about to revolutionise access to properties, enabling landlords to identify the last person to visit a property, and how long they stayed.

The SitexOrbis mould eradication service uses an immensely thorough three-stage treatment process to totally remove the fungal organisms that cause mould in buildings, thereby removing the proven Category One health risk to occupants' respiratory systems caused by moulds.

The SitexOrbis lone worker protection system enables workers to carry what looks like an ID card holder, but which, as well as carrying a card, is an Identisafe device packed with mobile telecoms to enable the worker to summon help.

UK Group Page: http://www.sitexorbis.co.uk

Full details and a detailed technical brochure are available from http://www.sitexorbis.com/biotech or +44(0)845-543-6416.


'/>"/>
SOURCE SitexOrbis
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Pennsylvania Health Department Offers Tips to Prevent Spread of Highly Contagious Norovirus
2. University of Denver uses gross messaging to increases handwashing, fight Norovirus
3. University of Denver uses gross messaging to increases handwashing, fight Norovirus
4. 6 simple steps to protect against and stop the spread of noroviruses
5. CeraLyte ORS to Prevent Dehydration from Norovirus Outbreak
6. dGianni to Unveil Exquisite New Lingerie Collection Aboard New York City Cruise Ship
7. In Two Weeks, Top CEOs From U.S. and Aboard Tackle Obamas Health Reform Plans at 6th Annual World Health Care Congress, April 14-16, Washington
8. AORN and Mercy Ships Collaborate to Increase Patient Care Aboard Hospital Ships
9. Carnival Cruise Lines Encourages Children to Dream Big With the Virtual Book of Dreams Contest
10. Cruise Ship Virus Vaccine Stems From Tobacco
11. Retirement Cruise Ship Nearing Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from PsychTests.com reveals that behind the tendency to set low expectations ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: